Position in DXCM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,966,940
+$284,671 QoQ
Shares Held
88,596
-2.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#257
of 966 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GF FUND MANAGEMENT CO. LTD. holds $27,271,599 across 13 Medical Devices names. DXCM ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
104,224 | $6,671,378 | |
| 2 | DXCM |
Dexcom Inc
This page
|
88,596 | $5,966,940 | |
| 3 | ABT |
Abbott Laboratories
|
47,558 | $4,315,412 | |
| 4 | SYK |
Stryker Corp
|
9,408 | $2,962,014 | |
| 5 | MDT |
Medtronic plc
|
35,120 | $2,747,437 | |
| 6 | BSX |
Boston Scientific Corp
|
41,184 | $1,757,733 | |
| 7 | EW |
Edwards Lifesciences Corp
|
16,089 | $1,455,410 | |
| 8 | STE |
STERIS plc
|
2,710 | $570,644 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,966,940 | 88,596 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $5,682,269 | 90,482 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $6,160,795 | 92,825 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $5,978,581 | 88,848 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $7,600,165 | 87,068 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $5,761,900 | 84,374 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $6,460,276 | 83,069 | Shares | Sole | 2025-02-19 | |
| No filing history on record for this holder in this stock. | ||||||